Plunkett Research Online: Zogenix Inc

ZOGENIX INC (ZGNX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Zogenix, Inc. is a pharmaceutical company that commercializes and develops products for the treatment of central nervous system disorders. Its current areas of focus are epilepsy and schizophrenia. Zogenix is responsible for developing Zohydro ER (hydrocodone bitartrate) extended-release capsules,.....



Zogenix Inc
Ticker: ZGNX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510-550-8300
Fax:
Address: 5858 Horton Street
Suite 455
Emeryville, CA 94608 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
ContactsDescription
Michael SmithCFO/Chief Accounting Officer/Executive VP/Secretary/Treasurer
Cam GarnerChairman of the Board/Director/Co-Founder
See More
Zogenix, Inc. is a pharmaceutical company that commercializes and develops products for the treatment of central nervous system disorders. Its current areas of focus are epilepsy and schizophrenia. Zogenix is responsible for developing Zohydro ER (hydrocodone bitartrate) extended-release capsules,.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Latham & Watkins LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Zogenix Europe Limited
Brabant Pharma Limited
Sumavel DosePro
ZX008
Relday
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: